Bokus
Devesh U. Kapoor, Swapnil Sharma, Dinky Gajiwala Jardosh - Nanocarriers for Targeted Therapy and Management of Ovarian Cancer, Häftad

Häftad, Engelska, 2027

Nanocarriers for Targeted Therapy and Management of Ovarian Cancer

Av Devesh U. Kapoor, Swapnil Sharma, Dinky Gajiwala Jardosh

1804 kr

Kommande

Beskrivning
Nanocarriers for Targeted Therapy and Management of Ovarian Cancer provides a comprehensive and up-to-date overview of nanomedicine strategies for improving ovarian cancer treatment. The book examines diverse nanocarrier platforms, including liposomes, solid lipid nanoparticles, polymeric nanoparticles, micelles, dendrimers, mesoporous silica nanoparticles, niosomes, nanogels, hydrogels, and exosome-based systems. It integrates advances in targeted and controlled drug delivery with tumor biology, pharmacokinetics, safety, regulatory considerations, artificial intelligence, and clinical translation. By bridging fundamental science and clinical applications, this multidisciplinary resource highlights emerging technologies, therapeutic challenges, and future opportunities for researchers, oncologists, pharmaceutical scientists, and students.

  • Provides cancer-specific chapters detailing advanced nanocarrier-based therapeutic delivery approaches
  • Covers targeted and controlled drug delivery strategies for ovarian cancer management
  • Integrates nanomedicine with clinical translation, safety, and regulatory considerations
  • Explores emerging AI-driven and exosome-based nanocarrier technologies
  • Bridges nanotechnology, pharmaceutical sciences, and clinical oncology for precision therapy
Produktinformation
  • Utgivningsdatum: 2027-03-01
  • Mått: 191 x 235 x undefined mm
  • Vikt: 450 g
  • Format: Häftad
  • Språk: Engelska
  • Antal sidor: 270
  • Förlag: Elsevier Science
  • ISBN: 9780443494468
Utforska kategorier
Mer om författaren

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Swapnil Sharma is a Professor in the Department of Pharmacy at Banasthali Vidyapith, Banasthali, Rajasthan, India. With over 19 years of academic and professional experience, he specializes in fundamental preclinical pharmacology. He has published over 250 research papers, contributed 10+ book chapters, and holds five granted patents, including 1 US and 1 European Patent. He has guided dozens of Ph.D. and several PG scholars. Also, he is a regular reviewer of various peer review journals belonging to various renowned publishing houses .Dr. Dinky Gajiwala is a consultant medical oncologist at Nirali Cancer Hospital, Navsari, with comprehensive clinical expertise in the management of adult solid tumors and hematological malignancies, including breast, gynecological, gastrointestinal, thoracic, urological, head-and-neck cancers, sarcomas, lymphoma, myeloma, and leukemia. She completed her MBBS from Veer Narmad South Gujarat University, followed by DNB Internal Medicine training at Holy Family Hospital and DNB Medical Oncology at Prince Aly Khan Hospital. Her clinical practice includes administration of chemotherapy, targeted therapy, immunotherapy, and palliative oncology care, along with procedures such as intrathecal chemotherapy and peripherally inserted central catheter placement. She is also experienced in both autologous and allogeneic bone marrow transplantation. Dr. Gajiwala actively participates in international oncology communities and is a member of European Society for Medical Oncology, American Society of Clinical Oncology, and Indian Society of Medical and Pediatric Oncology.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.